How to identify high quality stocks in a highly speculative market

Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Business Development Manager - Stock Doctor

Jun 15th, 2021
12:30pm - 1:30pm AEST
Register now

Supported by record low interest rates and unprecedented levels of government stimulus, equity markets have been on a tear since last year’s lows. But with international borders remaining shut for the immediate future and the outbreak of a highly infectious variant of COVID-19, there is a real risk to the speculative end of the market, especially among those in the travel and tourism industries.

Stock Doctor can help investors generate long term outperformance, not only by identifying and sticking to high quality businesses, but also by protecting them from investing in corporate disasters, like the recent accounting scandal of Freedom Foods Group (FNP) or newly listed intelligence software company Nuix Ltd (NXL).

“The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital” – Li Lu, Hedge Fund Manager.

Australia’s premier DIY share investing platform

Stock Doctor has been assisting members in managing their portfolios and identifying high-quality ASX stocks for decades. Backed by our proprietary Financial Health Methodology, Stock Doctor’s Star Growth Stocks have delivered market beating average annual returns of 17.83%* since 1995^, while our Star Income Stocks have returned 14.70% p.a.* since 2012^^.

Stock Doctor has the tools for all types of investors. For those who are trend sensitive, our proprietary technical indicators have helped members generate market leading returns over last twelve months and protected them from catastrophic share price declines during volatile and uncertain markets.

In our upcoming webinar, Kien Trinh, Head of Research, and Mathew Potts, Business Development Manager, will outline how Stock Doctor and our team of market experts can help you invest with confidence, control and peace of mind, whatever your investment goals.

Webinar Agenda

  • The importance of Financial Health in building a quality long-term investment portfolio
  • The quantitative methodology behind Lincoln’s outperforming Star Growth and Income Stock portfolios
  • Stock Doctor’s investment tools, education, and support for all types of investors.
  • Where to find opportunities heading into the new financial year
  • Q&A

Not to be missed EOFY sale

With our EOFY sale underway, there is no better time to experience the full power of the Stock Doctor platform with a free 14-day trial

Featuring all the tools and features you could need to grow and protect your investment portfolio, we are confident you will love what the platform has to offer. But be quick as there are only 250 memberships available until we implement a membership waitlist.

Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Business Development Manager - Stock Doctor

Jun 15th, 2021
12:30pm - 1:30pm AEST
Register now
The information in this communication is market commentary only and reflects Lincoln’s views and beliefs at the time of preparation, which are subject to change without notice. To obtain up-to-date information, please contact us.

Important: This communication is provided by or on behalf of Lincoln Indicators Pty Limited ABN 23 006 715 573 (Lincoln), as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167 for information and educational purposes only. This content may contain general financial product advice. It has been prepared without taking account of your personal circumstances and you should therefore consider its appropriateness in light of your objectives, financial situation and needs, before acting on it. Investments can go up and down. Past performance is not a reliable indicator of future performance. Shares and other investments may go up and down in value, and their past performance may not be repeated and gives no guarantee of future performance. Information in this communication was current as at the date of its preparation, unless otherwise stated, and may be subject to change.

You should read and consider our Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. Where our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Product Disclosure Statement (PDS) for the product at www.lincolnindicators.com.au before making any decision.

At the date of preparation of this communication, Lincoln, Lincoln Financial Group Pty Ltd or directors, employees and/or associates of these entities "may hold" interests in these ASX-listed companies. Further information about particular stocks held by these entities or persons from time to time is disclosed within the Stock Doctor program and may change at any time without notice.

Lincoln, Lincoln Financial Group Pty Ltd, any directors, employees and agents of these entities, make no representation and give no warranty as to the accuracy of this communication and do not accept any responsibility for any errors or inaccuracies in, or omissions from, this communication (whether negligent or otherwise) and are not liable for any loss or damage howsoever arising as a result of any person acting, or refraining from acting, in reliance on any information in this communication. No person should rely on this communication as it does not purport to be comprehensive. This disclaimer does not purport to exclude any rights under, or warranties implied by, law which may not be lawfully excluded.

Lincoln has taken precautions to minimise the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any downloadable content. We do not accept liability for any loss or damage caused by software viruses.

Copyright © 2021 Lincoln Indicators Pty Ltd. All rights reserved.

All financial services are provided by Lincoln Indicators Pty Ltd ABN 23 006 715 573 (Lincoln) as the Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167.